Amgen (NASDAQ: AMGN) reported Q3 EPS of $5.64, $0.60 better than the analyst estimate of $5.04. Revenue for the quarter came in at $9.56 billion versus the consensus estimate of $8.98 billion.

GUIDANCE:

Amgen sees FY2025 EPS of $20.60-$21.40, versus the consensus of $21.04. Amgen sees FY2025 revenue of $35.8-36.6 billion, versus the consensus of $35.64 billion.

For earnings history and earnings-related data on Amgen (AMGN) click here.